Biblio

2013
Liu Y, Fox V, Lei Y, Hu B, Joo K-I, Wang P. Synthetic niches for differentiation of human embryonic stem cells bypassing embryoid body formation. J Biomed Mater Res B Appl Biomater. 2013.
Suzuki O, Anada T. Synthetic octacalcium phosphate: A possible carrier for mesenchymal stem cells in bone regeneration. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:397-400.
Dolley-Sonneville PJ, Romeo LE, Melkoumian ZK. Synthetic surface for expansion of human mesenchymal stem cells in xeno-free, chemically defined culture conditions. PLoS One. 2013;8(8):e70263.
Goh PA, Caxaria S, Casper C, Rosales C, Warner TT, Coffey PJ, Nathwani AC. A Systematic Evaluation of Integration Free Reprogramming Methods for Deriving Clinically Relevant Patient Specific Induced Pluripotent Stem (iPS) Cells. PLoS One. 2013;8(11):e81622.
Diez D, Hutchins APaul, Miranda-Saavedra D. Systematic identification of transcriptional regulatory modules from protein-protein interaction networks. Nucleic Acids Res. 2013.
Zhu P, Chen M, Wang L, Ning Y, Liang J, Zhang H, Xu C, Chen S, Yao L. Systemic mesenchymal stem cells reduce growth rate of cisplatin-resistant ovarian cancer. Int J Clin Exp Pathol. 2013;6(11):2506-14.
Viswanath V, Phiske MM, Gopalani VV. Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations. Indian J Dermatol. 2013;58(4):255-68.
Ferrer-Lorente R, Bejar MTeresa, Tous M, Vilahur G, Badimon L. Systems biology approach to identify alterations in the stem cell reservoir of subcutaneous adipose tissue in a rat model of diabetes: effects on differentiation potential and function. Diabetologia. 2013.
Burman J, Fransson M, Tötterman TH, Fagius J, Mangsbo SM, Loskog ASi. T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis. Immunology. 2013.
Mardiros A, Santos CDos, McDonald T, Brown CE, Wang X, L Budde E, Hoffman L, Aguilar B, Chang W-C, Bretzlaff W, et al. T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and anti-tumor effects against human acute myeloid leukemia. Blood. 2013.
Zhou H, Grubisic I, Zheng K, He Y, P Wang J, Kaplan T, Tjian R. Taf7l cooperates with Trf2 to regulate spermiogenesis. Proc Natl Acad Sci U S A. 2013.
Ma N, Liao B, Zhang H, Wang L, Shan Y, Xue Y, Huang K, Chen S, Zhou X, Chen Y, et al. TALEN-mediated gene correction in integration-free β-thalassemia iPSCs. J Biol Chem. 2013.
Trentin DS, Silva DB, Amaral MW, Zimmer KR, Silva MV, Lopes NP, Giordani RB, Macedo AJ. Tannins Possessing Bacteriostatic Effect Impair Pseudomonas aeruginosa Adhesion and Biofilm Formation. PLoS One. 2013;8(6):e66257.
Martínez-Jiménez F, Papadatos G, Yang L, Wallace IM, Kumar V, Pieper U, Sali A, Brown JR, Overington JP, Marti-Renom MA. Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosis. PLoS Comput Biol. 2013;9(10):e1003253.
Li T, Pan Y-W, Wang W, Abel G, Zou J, Xu L, Storm DR, Xia Z. Targeted Deletion of the ERK5 MAP Kinase Impairs Neuronal Differentiation, Migration, and Survival during Adult Neurogenesis in the Olfactory Bulb. PLoS One. 2013;8(4):e61948.
Suen CM, Mei SHJ, Kugathasan L, Stewart DJ. Targeted delivery of genes to endothelial cells and cell- and gene-based therapy in pulmonary vascular diseases. Compr Physiol. 2013;3(4):1749-79.
Huang X-F, Xiang P, Chen J, Xing D-J, Huang N, Min Q, Gu F, Tong Y, Pang C-P, Qu J, et al. Targeted Exome Sequencing Identified Novel USH2A Mutations in Usher Syndrome Families. PLoS One. 2013;8(5):e63832.
Barar J, Omidi Y. Targeted Gene Therapy of Cancer: Second Amendment toward Holistic Therapy. Bioimpacts. 2013;3(2):49-51.
Heymann D, Rédini F. Targeted therapies for bone sarcomas. Bonekey Rep. 2013;2:378.
Dinner S, Advani R. Targeted therapy in relapsed classical hodgkin lymphoma. J Natl Compr Canc Netw. 2013;11(8):968-76.
Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, Lagadinou ED, Corbett C, Ye H, Liesveld JL, et al. Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells. J Biol Chem. 2013.
Bellodi C, Lidonnici MRosa, Hamilton A, G Helgason V, Soliera ARachele, Ronchetti M, Galavotti S, Young KW, Selmi T, Yacobi R, et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest. 2013;123(8):3634.
Bhutia SK, Das SK, Azab B, Menezes ME, Dent P, Wang X-Y, Sarkar D, Fisher PB. Targeting breast cancer initiating/stem cells with melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24). Int J Cancer. 2013.
Wang M-L, Chiou S-H, Wu C-W. Targeting cancer stem cells: emerging role of Nanog transcription factor. Onco Targets Ther. 2013;6:1207-1220.
Darini CY, Martin P, Azoulay S, Drici M-D, Hofman P, Obba S, Dani C, Ladoux A. Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential. Cell Death Dis. 2013;4:e706.

Pages